Polycythemia Vera with High Erythropoietin Level: Case Report
Journal Title: International Journal of Blood Research and Disorders - Year 2016, Vol 3, Issue 1
Abstract
Polycythemia Vera (PV) is a myeloproliferative disorder of bone marrow stem cells characterized by erythrocytosis. Elevated erythropoietin level strongly indicates secondary erythrocytosis and excludes PV diagnosis. However, patients with PV who co-present with Budd-Chiari syndrome (BCS) have been documented with elevated serum erythropoietin levels provided that JAK2 mutation is positive.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP350386
- DOI 10.23937/2469-5696/1410023
- Views 111
- Downloads 0
Polycomb Proteins in Hematopoiesis and Hematologic Malignancie
In recent years, the Polycomb group (PcG) of proteins has been revealed to be involved in the regulation of hematologic stem cell function and differentiation and have been broadly linked to hematologic malignancies. Pol...
Polycythemia Vera with High Erythropoietin Level: Case Report
Polycythemia Vera (PV) is a myeloproliferative disorder of bone marrow stem cells characterized by erythrocytosis. Elevated erythropoietin level strongly indicates secondary erythrocytosis and excludes PV diagnosis. Howe...
Successful Treatment of a Primary Cervical Diffuse Large B-cell Lymphoma with Rituximab-CHOP Immunochemotherapy
Introduction: Primary Large B-cell lymphoma of the cervix is a very rare disease. Because of the rarity of this tumor, it can lead to mistakes or delays in the diagnosis and proper therapy, and eventually becoming diagno...
Bone Marrow Necrosis: An Unusual Misdiagnosed Serious Complication
Bone Marrow Necrosis (BMN) is an uncommon syndrome characterized by destruction of hematopoietic tissue with preservation of the bone. It presents as localized or diffuse generalized process. Many underlying diseases can...
Chronic Use of Adalimumab as Potential Cause of Severe Thrombocytopenia in Psoriatic Arthritis Patient: The Need for Regular Monitoring of Cytopenias
Anti-tumor necrosis factor alpha (anti-TNFα) agents are used to treat inflammatory diseases with recognized safety and efficacy. Although they are rare, severe hematologic adverse effects are described and may be fatal....